Target intelligence / Profile preview

Cell-surface sialic acid (Sia) (Sia)

Target
Sia
Molecular classification
Carbohydrate, Glycan, Post-translational modification
01

Overview

Cell-surface sialic acids are a family of nine-carbon acidic monosaccharides typically found at the terminal positions of N-linked and O-linked glycans on glycoproteins and glycolipids (Varki A, 2008). They are essential components of the "sialome," playing pivotal roles in cell-cell recognition, molecular masking, and the regulation of the innate and adaptive immune systems (Cohen M, et al., 2010). By interacting with Sialic acid-binding immunoglobulin-type lectins (Siglecs), these residues function as "self-associated molecular patterns" (SAMPs) that suppress overactive immune responses (Läubli H, et al., 2020). In oncology, many tumors exhibit hypersialylation, which facilitates immune evasion by engaging inhibitory Siglecs on natural killer (NK) cells and macrophages (Pearce OM, et al., 2016). Furthermore, sialic acids serve as critical attachment points for numerous pathogens, most notably the influenza virus, which uses hemagglutinin to bind these residues for host cell entry (Skehel JJ, et al., 2000). Therapeutic interventions include neuraminidase inhibitors that prevent viral spread and emerging glyco-immune checkpoint inhibitors designed to disrupt the sialic acid-Siglec axis in the tumor microenvironment (Zhou X, et al., 2020).

Other names
N-acetylneuraminic acidNeu5AcSialic acid residuesTerminal sialic acidN-glycolylneuraminic acid
02

Mechanism of action

Inhibition of viral neuraminidase to prevent the cleavage of terminal sialic acid residues from host cell surfaces, thereby trapping viral progeny; blockade of sialic acid-binding receptors like P-selectin to prevent cell adhesion; and disruption of the sialic acid-Siglec immune checkpoint to enhance anti-tumor immunity (Varki A, 2008; Zhou X, et al., 2020).

03

Biological functions

Cell-cell recognitionImmune evasionViral entry receptorSignal transductionProtein stabilization
04

Disease associations

CancerInfectionInflammationAutoimmune disease
05

Safety considerations

Potential for systemic glycan disruption affecting normal cell-cell communication (Varki A, 2008)Risk of autoimmune reactions due to interference with Siglec-mediated "self" recognition (Läubli H, et al., 2020)Impairment of normal leukocyte trafficking and inflammatory responses (Pearce OM, et al., 2016)
06

Interacting drugs

Oseltamivir

6 more in the full profile.

07

Biomarkers

Sialyl-Lewis X (sLeX)Cancer Antigen 19-9 (CA19-9)Sialyl-Tn (STn) antigenTotal serum sialic acid (TSA)Siglec-9 expression levels

Beyond the preview

Go deeper on Cell-surface sialic acid (Sia) (Sia).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface sialic acid (Sia) (Sia).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call